FWIW, a golden cross does not create buying. Rather, above average buying is what creates the golden cross.
Also, expecting RFMK's golden cross to have good results may leave some investors disappointed. CVS* had a golden cross last month and is currently down approx. 60% from the day it's GC occurred.
While others have used the DTCC issues to suggest substantial lower levels coming, which may not happen, fact is, RFMK's DTCC issue is an embarassment in the least, for a company that supposedly consults in DTCC chills, and strongly draws into question RFMK mngmt's competency.
Also, the loss of DTCC eligibility considerably handicaps RFMK's ability to raise funds. Going forward, RFMK will only be able to sell new shares at even steeper discounts than they were already subject to, as a pinkie.
Seeing that yet another week has gone by without "Immediate" contracts signed strongly suggests unexpected legal issues, which result in unexpected legal fees, which translates to the need to raise yet more money to cover those unexpected legal fees.
The BIG question is, will the next round of dilution kill the pps like the last round did?
Some investors may reply to this post with a "blah, blah, blah", but ignoring/dismissing these points may be detrimental to one's financial health.
IHub's Most Marked Board: investorshub.advfn.com/boards/board.aspx?board_id=7489
